FDA Approves CICLOPIROX OLAMINE — Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. announced the approval to manufacture and market Ciclopirox Olamine following the FDA's greenlight of ANDA 076790. This approval provides the company a strategic foothold to capitalize on the topical antifungal market by offering a generic equivalent to established branded therapies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed